+ 1.29
+ 0.82%
+ 0.13
+ 0.07%

MedMen Sees Revenue Decline 40% In Q4, Looks Forward To 2021

October 16, 2020 11:20 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFFannounced a net revenue decline of 40% to $27.4 million in the fourth quarter.

The Los Angeles cannabis retailer blamed the revenue drop on the current health crisis stemming from the coronavirus pandemic.

In May, MedMen temporarily shut down five of its eight Florida-based stores due to the financial setbacks.

In addition, it estimates to achieve an increase of 37% in revenue over the first quarter of 2021.

"We made significant progress during the fourth quarter by focusing on retail profitability, optimizing our corporate infrastructure and strengthening our balance sheet ahead of an exciting new chapter for the Company," the company's Interim CEO Tom Lynch said in a prepared statement.

Earnings Breakdown

  • Systemwide Revenue (including the company's operation in California, Nevada, New York, Illinois, and Florida) totaled $157.1 million for the full year, up by 31% compared to 2019
  • Adjusted EBITDA (non-GAAP financial measure) was a loss of $116.1 million for the full year, versus a loss of $169.3 million in 2019
  • Fourth-quarter gross margin was 40% versus 32% in the previous quarter
  • Selling, general and administrative expenses (non-GAAP financial measure) for the quarter amounted to $13.7 million, down by 21% sequentially and 58% year-over-year
  • Negative adjusted EBITDA (non-GAAP financial measure) of $23.3 million for the last three months of this fiscal year, versus a loss of $26.1 million in the prior period
  • The company had $575.4 million in total assets as of June 27

Meanwhile, in August, MedMen tapped NBA Player and Viola Inc.'s founder Al Harrington to its board of directors.

Related Articles

MMA Pro Elias Theodorou Keeps Fighting For Cannabis Rights

Professional MMA fighter Elias Theodorou recently spoke with Benzinga about his efforts to fight the stigma against cannabis use and the uphill battle that comes with it. read more

Precision Extraction Solutions Is On The Hunt For Capital

Precision Extraction Solutions is hoping to raise at least $10 million in venture capital.  That's according to the Troy, Michigan-based company's founder and CTO Nick Tennant. read more

Cannabis Regulatory Update: SD Gov Says 'No' To Legalization, PA Tweaks DUI Law

South Dakota Gov. Urges Against Marijuana Legalization As Election Day nears on Nov. 3, and five states consider some form of cannabis legalization, South Dakota governor Kristi Noem is advocating against marijuana. read more

Organigram Invests In Hyasynth Biologicals, Parts Ways With Executives

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has invested an additional $2.5 million in a private biotechnology company Hyasynth Biologicals Inc. read more

Cannabis Movers & Shakers: Avicanna, Halo, Blockers BlockChain, Fyllo, Pet Releaf, Indus

Peruse the latest corporate shake-ups in the cannabis industry: Avicanna, Halo Elect Directors At Annual General Meetings of Shareholders read more